United States · FDA National Drug Code directory
ADVAIR HFA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0173-0715_bea52e57-aa75-4dce-8cfb-a163bbc22be2
- Product NDC
- 0173-0715
- Form
- AEROSOL, METERED
- Composition / generic term
- fluticasone propionate and salmeterol xinafoate
- Labeler
- GlaxoSmithKline LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20080929
- Source listing expiry
- 20271231
Source-listed ingredients
- FLUTICASONE PROPIONATE — 45 ug/1
- SALMETEROL XINAFOATE — 21 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INHALER in 1 CARTON (0173-0715-20) / 120 AEROSOL, METERED in 1 INHALER · 0173-0715-20
- 1 INHALER in 1 CARTON (0173-0715-22) / 60 AEROSOL, METERED in 1 INHALER · 0173-0715-22
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →